Brustbildgebung / Mammografie – Bildgebung und Vorgehen bei präinvasiven Läsionen der Mamma

Präinvasive Läsionen der Brust umfassen ein Spektrum von biologisch und klinisch heterogenen, neoplastischen Läsionen mit einem sehr unterschiedlichen Progressionspotenzial zum invasiven Brustkrebs. In dieser Übersicht werden Definitionen, diagnostische Kriterien und klinische Schlussfolgerungen zu folgenden Entitäten vorgestellt: duktales Carcinoma in situ (DCIS), atypische duktale Hyperplasie (ADH), flache epitheliale Atypie (FEA), lobuläre Neoplasie (LN).

• Literatur

• 1 Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 2003; 5: 313-319
• 2 Buerger H, Otterbach F, Simon R et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 1999; 187: 396-402
• 3 Simpson PT, Reis-Filho JS, Gale T et al. Molecular evolution of breast cancer. J Pathol 2005; 205: 248-254
• 4 Ellis IO. Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology. Mod Pathol 2010; 23: S1-S7
• 5 Simpson PTP, Gale TB, Reis-Filho JSM et al. Columnar Cell Lesions of the Breast: The Missing Link in Breast Cancer Progression? A Morphological and Molecular Analysis. American Journal of Surgical Pathology 2005; 29: 734-746
• 6 Buerger H, Schmidt H, Beckmann A et al. Genetic characterisation of invasive breast cancer: a comparison of CGH and PCR based multiplex microsatellite analysis. J Clin Pathol 2001; 54: 836-840
• 7 Reis-Filho JS, Simpson PT, Gale T et al. The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol Res Pract 2005; 201: 713-725
• 8 American College of Radiology (ACR). Illustrated breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology; 2003
• 9 Page DL, Dupont WD, Rogers LW et al. Continued local recurrence of carcinoma 15–25 years after a diagnosis of Low-Grade-ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995; 76: 1197-1200
• 10 Wells CA, Amendoeira I, Apostolikas N et al. Quality assurance guidelines for pathology – Cytological and histological non-operative diagnosis. In: Perry NM, Broeders M, de Wolf C, et al., eds European guidelines for quality assurance in breast cancer screening and diagnosis. Luxembourg: Office for Official Publication of the European Communities; 2006
• 11 Weigel S, Girnus R, Czwoydzinski J et al. Digital mammography screening: average glandular dose and first performance parameters. Fortschr Röntgenstr 2007; 179: 892-895
• 12 Hartmann LC, Sellers TA, Frost MH et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005; 353: 229-237
• 13 Degnim AC, Visscher DW, Berman HK et al. Stratification of Breast Cancer Risk in Women With Atypia: A Mayo Cohort Study. J Clin Oncol 2007; 25: 2671-2677
• 14 Collins LC, Baer HJ, Tamimi RM et al. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses“ Health Study. Cancer 2007; 109: 180-187
• 15 Thomssen C, Harbeck N. Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer – Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast Cancer. Breast Care (Basel) 2010; 5: 345-351
• 16 Lieske B, Ravichandran D, Alvi A et al. Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised. Eur J Surg Oncol 2008; 34: 1293-1298
• 17 El-Sayed ME, Rakha EA, Reed J et al. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology 2008; 53: 650-657
• 18 Weigel S, Decker T, Korsching E et al. Minimal Invasive Biopsy Results of „Uncertain Malignant Potential“ in Digital Mammography Screening: High Prevalence but also High Predictive Value for Malignancy. Fortschr Röntgenstr 2011; 183: 743-748
• 19 Flegg K, Flaherty J, Bicknell A et al. Surgical outcomes of borderline breast lesions detected by needle biopsy in a breast screening program. World Journal of Surgical Oncology 2010; 8: 78
• 20 Bijker N, Rutgers EJ, Peterse J L et al. Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10 853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol 2001; 27: 135-140
• 21 de Mascarel I, Macgrogan G, Mathoulin-Pelissier S et al. Epithelial atypia in biopsies performed for microcalcifications. practical considerations about 2833 serially sectioned surgical biopsies with a long follow-up. Virchows Arch 2007; 451: 1-10
• 22 Eusebi V, Feudale E, Foschini MP et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11: 223-235
• 23 Badve S, Dabbs DJ, Schnitt SJ et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol 2011; 24: 157-167
• 24 Abdel-Fatah TMA, Powe DG, Hodi Z et al. Morphologic and Molecular Evolutionary Pathways of Low Nuclear Grade Invasive Breast Cancers and Their Putative Precursor Lesions: Further Evidence to Support the Concept of Low Nuclear Grade Breast Neoplasia Family. The American Journal of Surgical Pathology 2008; 32: 513-523
• 25 Kunju LP, Kleer CG. Significance of flat epithelial atypia on mammotome core needle biopsy: should it be excised?. Human Pathology 2007; 38: 35-41
• 26 Weigel S, Decker T, Korsching E et al. Calcifications in Digital Mammographic Screening: Improvement of Early Detection of Invasive Breast Cancers?. Radiology 2010; 255: 738-745
• 27 Foote FW, Steward FW. Lobular carcinoma in situ. American Journal of Pathology 1941; 17: 491-496
• 28 Haagensen CD, Lane N, Lattes R et al. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737-769
• 29 Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC-Press; Classification of Tumours. World Health Organisation 2003
• 30 Lakhani SR, Audretsch W, Cleton-Jensen AM et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?. European Journal of Cancer 2006; 42: 2205-2211
• 31 Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002; 440: 134-138
• 32 Hanby AM, Hughes TA. In situ and invasive lobular neoplasia of the breast. Histopathology 2008; 52: 58-66
• 33 Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol 2001; 176: 1255-1259
• 34 Page DL, Kidd TE, Dupont WD et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991; 22: 1232-1239
• 35 Akashi-Tanaka S, Fukutomi T, Nanasawa T et al. Treatment of noninvasive carcinoma: fifteen-year results at the National Cancer Center Hospital in Tokyo. Breast Cancer 2000; 7: 341-344
• 36 Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev 2005; 14: 1008-1011
• 37 Frykberg ER. Lobular Carcinoma In Situ of the Breast. Breast J 1999; 5: 296-303
• 38 Ottesen GL, Graversen HP, Blichert-Toft M et al. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 1993; 17: 14-21
• 39 Ottesen GL, Graversen HP, Blichert-Toft M et al. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000; 62: 197-210
• 40 Goldstein NS, Kestin LL, Vicini FA. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer 2001; 92: 738-747
• 41 Page DL, Schuyler PA, Dupont WD et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003; 361: 125-129
• 42 Hussain M, Cunnick GH. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast – a review. European Journal of Surgical Oncology 2011; 37: 279-289
• 43 Ciocca RM, Li T, Freedman GM et al. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol 2008; 15: 2263-2271
• 44 Deutsche Gesellschaft für Senologie, Deutsche Krebsgesellschaft. Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland. München: Zuckschwerdt; 2008